IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.0020
+0.0019 (1,900.00%)
At close: Aug 10, 2026

IO Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
06112466184-
Market Cap Growth
-99.99%-51.06%86.88%-64.06%--
Enterprise Value
-12.541.78-17.5-74.04-27.110

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
0.011.290.930.480.87-

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/EBITDA Ratio
--0.191.040.66-
EV/EBIT Ratio
--0.191.040.66-
EV/FCF Ratio
--0.241.230.66-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
19.020.030.010.0200
Net Debt / Equity Ratio
-13.77-1.24-1.06-1.01-1.000.10
Net Debt / EBITDA Ratio
0.140.621.551.975.130.34
Net Debt / FCF Ratio
0.160.711.952.315.190.34
Quick Ratio
1.673.089.1113.3620.531.12
Current Ratio
2.013.339.3713.8821.521.85
Return on Equity (ROE)
-368.69%-106.00%-63.29%-40.74%-76.86%34.11%
Return on Assets (ROA)
-169.18%-88.49%-61.06%-38.88%-36.22%-179.46%
Return on Invested Capital (ROIC)
942.14%1036.99%2177.46%29441.08%23585.91%1264.96%
Return on Capital Employed (ROCE)
-263.54%-103.90%-66.23%-40.45%-38.43%-389.74%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Buyback Yield / Dilution
-0.31%-51.31%-51.10%-564.62%-2346.74%-
Total Shareholder Return
-0.31%-51.31%-51.10%-564.62%-2346.74%-